Selventa, a provider of data-analysis software and services for pharmaceutical and biotechnology companies, has named Dr. David Fryburg chief medical officer.
Selventa names Fryburg chief medical officer
Fryburg most recently was executive director and leader of global translational medicine for cardiovascular, metabolic and endocrine diseases at Pfizer. In his new role, he will help develop Selventa's scientific strategy and drive efforts to optimize the company's pharmaceutical portfolio, according to a news release. Fryburg's age was unavailable at deadline.
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.